Clinical Trial Update: The Use of Botox in Advanced Parkinson's Patients Experiencing Pain [Phase 4]

View source ↗

Summary

This clinical trial update reports on the use of Botox (onabotulinumtoxinA) for pain in advanced Parkinson's disease patients. The study is a Phase 4 trial spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Parkinson's Disease | Phase 4 | Status: UNKNOWN